Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer Journal Article
| Authors: | Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; Manova-Todorova, K.; Mata, D. A.; Egger, J. V.; Rizvi, H.; Socci, N. D.; Kelly, D. W.; Rosiek, E.; Meng, F.; Tam, G.; Fan, N.; Drilon, A.; Yu, H. A.; Riely, G. J.; Rekhtman, N.; Villalonga, A. Q.; Dogan, S.; Bhanot, U.; Gonen, M.; Loomis, B.; Hellmann, M. D.; Schoenfeld, A. J.; Ladanyi, M.; Rudin, C. M.; Vanderbilt, C. M. |
| Article Title: | Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 28 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-10-01 |
| Start Page: | 3339 |
| End Page: | 3349 |
| Language: | English |
| DOI: | 10.1200/jco.23.01488 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PUBMED: | 39038258 |
| PMCID: | PMC11600405 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Charles M. Rudin -- Source: CINAHL Plus with Full Text |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
